Access cutting-edge drug clearance after severe burn injury treatment through this phase 4 clinical trial at a research site in Memphis. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Memphis location
Preparing your pre-screening questions…
Access drug clearance after severe burn injury specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related drug clearance after severe burn injury treatment provided free
Check if you qualify for this drug clearance after severe burn injury clinical trial in Memphis, TN
No-Cost Study Care
Local to Memphis
Convenient for TN residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Cefiderocol is a powerful, broad spectrum antibiotic approved to treat hospital-acquired or ventilator associated pneumonia and urinary tract infections. Although cefiderocol has labeled dosing recommendations, including augmented renal clearance, patients with burn injury remain an unstudied population at high risk for MDR pathogens. The primary objective of this study is to evaluate the pharmacokinetic principles of cefiderocol in patients after acute burn injury. Findings from this study will determine the dose and interval necessary to maintain therapeutic concentrations of cefiderocol in patients after burn injury for adequate bactericidal activity, prevention of resistance, and treatment outcomes.
Sponsor: University of Tennessee
Yes, this clinical trial (NCT07465432) has an active research site in Memphis, TN that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for drug clearance after severe burn injury treatment options in Memphis, TN, this clinical trial (NCT07465432) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Memphis research site is actively enrolling participants for this phase 4 clinical trial. You'll receive care from experienced drug clearance after severe burn injury specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all drug clearance after severe burn injury clinical trials near you to find additional studies recruiting in your area.
See all atrial fibrillation clinical trials recruiting in Memphis — not just this study.
Browse Atrial Fibrillation Trials in Memphis →